Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.8.0.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Revenues      
License and other revenue $ 25,000,000 $ 0 $ 0
Product revenue, net 1,910,403 0 0
Sales force revenue 278,165 0 0
Grant revenue 624,569 1,152,987 0
Total revenues, net 27,813,137 1,152,987 0
Operating expenses:      
Cost of product sales 635,648 0 0
Research and development 4,372,578 10,149,879 6,587,183
General and administrative 7,941,584 7,083,155 4,422,764
Sales and marketing 973,345 0 0
Total operating expenses 13,923,155 17,233,034 11,009,947
Income (loss) from operations 13,889,982 (16,080,047) (11,009,947)
Other income (expense):      
Change in fair value of warrant liability, unit purchase option liability and investor rights obligation (29,624) 72,625 1,313,049
Interest expense, net (24,016) (464,181) (793,205)
Total other (expense) income (53,640) (391,556) 519,844
Net income (loss) before taxes 13,836,342 (16,471,603) (10,490,103)
Income tax expense 1,966,519 0 0
Net income (loss) after taxes 11,869,823 (16,471,603) (10,490,103)
Net income (loss) attributable to common stockholders $ 7,772,084 $ (16,471,603) $ (10,490,103)
Net income (loss) per share of common stock, basic (in dollars per share) $ 0.42 $ (1.87) $ (4.71)
Net income (loss) per share of common stock, diluted (in dollars per share) $ 0.42 $ (1.87) $ (4.71)
Weighted average shares of common stock outstanding, basic (in shares) 18,410,005 8,830,396 2,226,023
Weighted average number of shares of common stock outstanding, diluted (in shares) 18,754,799 8,830,396 2,226,023